What is the recommended taper schedule for prednisone (corticosteroid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Tapering Recommendations

Prednisone tapering should be individualized based on initial dose, duration of treatment, and underlying condition, with high doses (>30 mg/day) reduced to 10 mg/day within 4-8 weeks, then by 1 mg every 4 weeks until discontinuation. 1, 2

General Principles

  • For courses longer than 3 weeks, tapering is necessary to prevent adrenal insufficiency 1
  • Single daily dosing is preferred over divided doses except in special situations such as prominent night pain while on low doses (<5 mg daily) 1, 2
  • Morning administration (before 9 am) is recommended to minimize adrenal suppression, as this coincides with the body's natural cortisol peak 3

Specific Tapering Schedules by Initial Dose

High Initial Doses (>30 mg/day)

  • Reduce to 10 mg/day within 4-8 weeks 1, 2
  • Then taper by 1 mg every 4 weeks until discontinuation 1

Medium Initial Doses (10-30 mg/day)

  • Taper by 5 mg every week until reaching 10 mg/day 1, 2
  • Then slow the taper to 2.5 mg/week until reaching 5 mg/day 1, 2
  • At 5 mg/day, further reduce by 1 mg every 2-4 weeks 2

Low Initial Doses (<10 mg/day)

  • Taper by 1 mg every 4 weeks 1, 2
  • Alternative approach: Use 1.25 mg decrements with alternate-day schedules (e.g., 10/7.5 mg alternate days) 2

Disease-Specific Recommendations

For Polymyalgia Rheumatica

  • Initial dose: 12.5-25 mg prednisone equivalent daily 1, 2
  • Initial tapering: Reduce to 10 mg/day within 4-8 weeks 1, 2
  • Maintenance tapering: Reduce by 1 mg every 4 weeks until discontinuation 1, 2

For Rheumatoid Arthritis

  • Daily doses should not exceed 10 mg/day 4
  • Tapering should be done slowly using 1 mg decrements every 2-4 weeks 1, 4
  • Consider divided doses (e.g., 5 mg twice daily) if needed for symptom control 4

For Autoimmune Hepatitis

  • For adults: Reduce by 5 mg every week until 10 mg/day, then further reduction by 2.5 mg/week until 5 mg daily 1
  • For children: Start with 1-2 mg/kg/day (up to 60 mg/day), taper over 6-8 weeks to 0.1-0.2 mg/kg daily or 5 mg daily 2

For Myasthenia Gravis

  • Evidence suggests that a rapid tapering regimen may be more effective than slow tapering 5
  • Rapid tapering (starting at 0.75 mg/kg/day with earlier decrease once improved) showed better outcomes than slow tapering in patients also receiving azathioprine 5

Managing Relapse During Tapering

  • If symptoms recur during tapering, return to the pre-relapse dose 1, 2
  • Then gradually decrease within 4-8 weeks to the dose at which relapse occurred 1, 2
  • Consider adding steroid-sparing agents if multiple relapses occur 1, 2

Special Considerations

  • For asthma exacerbations, evidence suggests that an abrupt discontinuation after a short course (7-10 days) may be as effective as tapering, with no difference in relapse rates or adrenal suppression 6, 7
  • Alternate day therapy (twice the usual daily dose administered every other morning) may help minimize pituitary-adrenal suppression and other side effects during long-term treatment 3
  • Calcium (800-1,000 mg/day) and vitamin D (400-800 units/day) supplementation should be initiated with prednisone treatment to prevent bone loss 4

Common Pitfalls to Avoid

  • Tapering too quickly, which may lead to disease flare or adrenal insufficiency 1
  • Using high initial doses (>30 mg/day) without clear indication 1
  • Failing to provide patients with clear instructions about the tapering schedule 1, 2
  • Abrupt withdrawal of therapy after long-term use, which can precipitate adrenal crisis 3

References

Guideline

Prednisone Tapering Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prednisone Tapering Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Double-blind trial of steroid tapering in acute asthma.

Lancet (London, England), 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.